VisionClearBlue is, at its core, a health-impact business: it exists to reduce avoidable blindness and expand access to specialist eye care in a country that is chronically under-served. Its ESG framework is therefore substantive, not cosmetic, and aligns directly with the mandates of development-finance and impact-health investors.
Social and health impact
- Access & avoidable blindness — specialist eye care and cataract surgery in provinces where private ophthalmology is scarce, reducing preventable sight loss.
- Diabetic-eye & school screening — large-scale diabetic-retinopathy and school vision screening catch disease early, when it is treatable.
- Skills & jobs — over 300 skilled healthcare jobs, and the longer-term ambition of specialist training and research to grow the ophthalmic workforce.
- Affordability — medical-aid partnerships and payment plans widen access beyond the highest-income patients.
|
Impact metric |
Year 1 |
At maturity |
|---|---|---|
|
Provinces served |
3 |
9 (all) |
|
Consultations / year |
~24,000 |
~180,000 |
|
Surgeries / year |
~2,700 |
~20,000 |
|
Skilled jobs |
~90 |
~300 |
Governance and environment
Clinical governance, credentialing, outcome audit, infection control and patient safety, is the foundation of the Group’s ESG framework, alongside B-BBEE participation, data-privacy compliance for electronic medical records, and environmentally efficient clinic design. The Group will report against health-outcome and access metrics from the outset, both because impact investors require it and because that data is a commercial and reputational asset.